Overview
Luke Nordquist is an Oncologist in Omaha, Nebraska. Dr. Nordquist is highly rated in 17 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and Prostatectomy.
His clinical research consists of co-authoring 31 peer reviewed articles and participating in 25 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
Locations
17607 Gold Plz, Omaha, NE 68130
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
25 Clinical Trials
Fred & Pamela Buffett Cancer Center-Nebraska Medical Center
Nicole Shonka is an Oncologist in Omaha, Nebraska. Dr. Shonka is highly rated in 42 conditions, according to our data. Her top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.
Oncology Hematology West PC
Kirsten Leu is an Oncologist in Omaha, Nebraska. Dr. Leu has been practicing medicine for over 30 years is highly rated in 39 conditions, according to our data. Her top areas of expertise are Angiosarcoma, Adult Soft Tissue Sarcoma, Alveolar Soft Part Sarcoma, and Epithelioid Sarcoma.
Fred & Pamela Buffett Cancer Center - Nebraska Medical Center
Robert Bociek is an Oncologist in Omaha, Nebraska. Dr. Bociek has been practicing medicine for over 38 years is highly rated in 25 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Luke Nordquist
How do I make an appointment with Dr. Luke Nordquist?
You can book an appointment with Dr. Luke Nordquist by calling their office at 402-991-8468. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Luke Nordquist a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Luke Nordquist is classified as an Elite expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Luke Nordquist specialize in?
While Dr. Luke Nordquist is a Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Renal Cell Carcinoma (RCC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Luke Nordquist participate in research or clinical trials?
Yes. Dr. Luke Nordquist has published 31 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Luke Nordquist's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Luke Nordquist accept my insurance?
Dr. Luke Nordquist accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 402-991-8468 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Prostate CancerDr. Nordquist isElite. Learn about Prostate Cancer.
- Distinguished
- Adult Soft Tissue SarcomaDr. Nordquist isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Nordquist isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Nordquist isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Nordquist isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Nordquist isDistinguished. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Nordquist isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Advanced
- AgranulocytosisDr. Nordquist isAdvanced. Learn about Agranulocytosis.
- Bladder CancerDr. Nordquist isAdvanced. Learn about Bladder Cancer.
- ChoriocarcinomaDr. Nordquist isAdvanced. Learn about Choriocarcinoma.
- Chronic Familial NeutropeniaDr. Nordquist isAdvanced. Learn about Chronic Familial Neutropenia.
- Non-Muscle Invasive Bladder CancerDr. Nordquist isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Severe Congenital NeutropeniaDr. Nordquist isAdvanced. Learn about Severe Congenital Neutropenia.
- Experienced
- Adrenal CancerDr. Nordquist isExperienced. Learn about Adrenal Cancer.
- AnemiaDr. Nordquist isExperienced. Learn about Anemia.
- Bone TumorDr. Nordquist isExperienced. Learn about Bone Tumor.
- Hereditary NeuroblastomaDr. Nordquist isExperienced. Learn about Hereditary Neuroblastoma.
- Lacrimal Gland TumorDr. Nordquist isExperienced. Learn about Lacrimal Gland Tumor.
- Lymphofollicular HyperplasiaDr. Nordquist isExperienced. Learn about Lymphofollicular Hyperplasia.